sanglah general chemotherapy at fluorouracil … · the risk factor of neutropenia on locally...

7
THE RISK FACTOR OF NEUTROPENIA ON LOCALLY ADVANCED BREAST CANCER PATIENTS TREATED WITH FIRST CYCLE CYCLOPHOSPHAMIDE, DOXORUBICINE, 5- FLUOROURACIL CHEMOTHERAPY AT SANGLAH GENERAL FILE T IME SUBMIT T ED 24-JUN-2016 09:28AM SUBMISSION ID 686070371 WORD COUNT 2701 CHARACT ER COUNT 15535 BMJ_2012_VOL_1_NO_3.DOCX (36.88K)

Upload: others

Post on 24-Sep-2019

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,

THE RISK FACTOR OFNEUTROPENIA ON LOCALLY

ADVANCED BREAST CANCERPATIENTS TREATED WITH

FIRST CYCLECYCLOPHOSPHAMIDE,

DOXORUBICINE, 5-FLUOROURACIL

CHEMOTHERAPY ATSANGLAH GENERAL

FILE

TIME SUBMITTED 24-JUN-2016 09:28AM

SUBMISSION ID 686070371

WORD COUNT 2701

CHARACTER COUNT 15535

BMJ_2012_VOL_1_NO_3.DOCX (36.88K)

Page 2: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,

HOSPITAL DENPASAR, BAby Dr. I Wayan Sudarsa

Page 3: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,
Page 4: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,
Page 5: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,
Page 6: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,
Page 7: SANGLAH GENERAL CHEMOTHERAPY AT FLUOROURACIL … · the risk factor of neutropenia on locally advanced breast cancer patients treated with first cycle cyclophosphamide, doxorubicine,

FINAL GRADE

/0

THE RISK FACTOR OF NEUTROPENIA ON LOCALLYADVANCED BREAST CANCER PATIENTS TREATED WITHFIRST CYCLE CYCLOPHOSPHAMIDE, DOXORUBICINE, 5-FLUOROURACIL CHEMOTHERAPY AT SANGLAH GENERALHOSPITAL DENPASAR, BAGRADEMARK REPORT

GENERAL COMMENTS

Instructor

PAGE 1

PAGE 2

PAGE 3

PAGE 4

PAGE 5